(Total Views: 771)
Posted On: 02/28/2022 9:13:02 AM
Post# of 148878
Initial report of mTNBC results was released 8/25. We're now six months past that.
I know there is a long list of updates for which we are waiting, but this seems to be one of the most impactful and accessible.
https://www.cytodyn.com/investors/news-events...uch-as-980
CytoDyn’s Final mTNBC Report Indicates as Much as 980% Increase in 12-Month Overall Survival and Up to 660% in 12-Month Modified Progression Free Survival
August 25, 2021 8:00am EDT
Decreases in Circulating Tumor Cells after leronlimab induction were seen in 73% of the patients and associated with increase in PFS and OS
I know there is a long list of updates for which we are waiting, but this seems to be one of the most impactful and accessible.
https://www.cytodyn.com/investors/news-events...uch-as-980
CytoDyn’s Final mTNBC Report Indicates as Much as 980% Increase in 12-Month Overall Survival and Up to 660% in 12-Month Modified Progression Free Survival
August 25, 2021 8:00am EDT
Decreases in Circulating Tumor Cells after leronlimab induction were seen in 73% of the patients and associated with increase in PFS and OS
(7)
(0)Scroll down for more posts ▼
